How the sprint for a coronavirus vaccine transformed Moderna into a $39 billion biotech powerhouse that's poised to reshape biotech

4:07am PST - November 21st, 2020    moderna stock - Business Insider

Summary List Placement In January, Stéphane Bancel, the chief executive of Moderna, was skimming through the news on his iPad while vacationing with his family in the south of France. A headline stopped his finger: "Health Officials Work to Solve China's Mys…